🇺🇸 Fentanyl-TTS in United States

33 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Nausea — 5 reports (15.15%)
  2. Dizziness — 4 reports (12.12%)
  3. General Physical Health Deterioration — 4 reports (12.12%)
  4. Altered State Of Consciousness — 3 reports (9.09%)
  5. Anaemia — 3 reports (9.09%)
  6. Drug Dependence — 3 reports (9.09%)
  7. Drug Interaction — 3 reports (9.09%)
  8. Pneumonia — 3 reports (9.09%)
  9. Vomiting — 3 reports (9.09%)
  10. Blood Urine Present — 2 reports (6.06%)

Source database →

Other Pain Management approved in United States

Frequently asked questions

Is Fentanyl-TTS approved in United States?

Fentanyl-TTS does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Fentanyl-TTS in United States?

Janssen-Cilag, S.A. is the originator. The local marketing authorisation holder may differ — check the official source linked above.